『Alzheimer's Disease (Audio)』のカバーアート

Alzheimer's Disease (Audio)

Alzheimer's Disease (Audio)

著者： UCTV
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり
Don't miss these vital updates on the latest in Alzheimer's and dementia care and research from the University of California.Copyright 2024 Regents of the University of California 科学
エピソード
  • Transforming Brain Health

    Transforming Brain Health
    2026/09/22
    More than 7 million Americans are living with Alzheimer's, according to the Alzheimer's Association. UC Davis researcher Alyssa Weakley is working on I-Care, a new technology that's helping Alzheimer's patients live longer in their own homes. At UC Davis, our researchers are working to better understand the causes of dementia, including Alzheimer’s, its most common form, while advancing understanding and improving care for those affected. Through innovative studies, we’re paving the way for new treatments and strategies to slow, prevent and ultimately transform how we approach these complex neurological conditions. Series: "UC Davis News" [Health and Medicine] [Show ID: 41737]
    続きを読む 一部表示
    1 分
  • Improving Early Alzheimers Detection in Women by Integrating Multimodal Data Into Clinical Decision Tools with Iris Broce-Diaz Ph.D.

    Improving Early Alzheimers Detection in Women by Integrating Multimodal Data Into Clinical Decision Tools with Iris Broce-Diaz Ph.D.
    2026/08/06
    Alzheimer’s disease can begin developing years before memory and thinking problems become noticeable. Iris Broce-Diaz, Ph.D., of UC San Diego is developing accessible, noninvasive, and cost-effective tools to help primary care physicians and neurologists identify people at higher risk earlier. Her models combine information from cognitive assessments, brain imaging, genetics, and PET scans to estimate the likelihood that mild cognitive impairment will progress within five years. Combining multiple measures improves the models’ ability to separate higher- and lower-risk patients. Broce-Diaz also plans to add women-specific factors, including menopause history, hormone therapy, reproductive history, endocrine markers, and symptoms. The goal is to support better referrals, guide monitoring, and help eligible patients consider treatment sooner. Earlier risk assessment could also strengthen clinical trials and make dementia care more useful across different health systems. Series: "Motherhood Channel" [Health and Medicine] [Show ID: 41632]
    続きを読む 一部表示
    14 分
  • Alzheimer's and Other Neurodegenerative Diseases: From Mechanisms to (Faltering) Therapies - Shiley Endowed Lecture

    Alzheimer's and Other Neurodegenerative Diseases: From Mechanisms to (Faltering) Therapies - Shiley Endowed Lecture
    2026/04/10
    Alzheimer’s disease unfolds over many years through a complex interplay of amyloid, tau, genetics, lipid biology, and the brain’s immune response. John Hardy, Ph.D., explains how rare inherited forms of Alzheimer’s disease helped shape current thinking about how the disease begins, then connects those discoveries to broader questions about late onset disease and why it develops differently across people. Hardy shows that amyloid and tau are linked but not identical, and argues that problems with protein buildup and clearance both matter in understanding the disease. He also emphasizes that Alzheimer’s is not a single event but a long process, which makes prediction, diagnosis, and treatment especially difficult. While current amyloid-targeting therapies can help and show measurable benefit, Hardy says they do not stop the disease, underscoring the need for earlier diagnosis, better treatments, and wider access to care Series: "Shiley Endowed Lecture" [Health and Medicine] [Show ID: 41250]
    続きを読む 一部表示
    1 時間 19 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません